Delivery Order SPE2DB24D2010-SPE2DB24FZVS0

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $6,328.98 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of epinephrine auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support the...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $3,053.64 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This fixed-price contract is for the supply of 4,564,370,730 units of the epinephrine 0.3 mg auto-injector medical product. The contract has an ultimate completion date of April 24, 2024 and was awarded on April 23,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,887.78 firm-fixed-price delivery order contract for the supply of 4564545872 Epinephrine 0.3 mg Auto-Injectors. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of epinephrine auto-injectors. The contract has a potential value of $1,495.30 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order. No set-aside designation was used. In addition, Amerisourcebergen Drug Corp holds an indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Epinephrine 0.15 mg auto-injectors. This contract, valued at $1,267.21, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a Delivery Order contract worth $1,196.24 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Epinephrine 0.3 mg Auto-Injectors, with a completion date of June 12, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $16,588.87 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,359,634 units of epinephrine 0.3 mg auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of epinephrine auto-injectors. The contract has a potential value of $1,960.08 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and the delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the supply of Epinephrine 0.3 mg auto-injector devices. The delivery order, valued at $1,514.33, has a firm fixed price and is scheduled for completion by June 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Epinephrine 0.3 mg auto-injectors. The delivery order, valued at $3,009.25, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and operates as a for-profit organization. This award is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZVS0
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Delivery Order valued at $11,098.25 for the supply of Epinephrine 0.3 mg Auto-Injector. This Firm Fixed Price contract has a completion date of July 1, 2024 and was awarded on June 28, 2024.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside and was made on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.

Generated 9/27/24, 9:22 AM